New research could increase survival rates for ovarian cancer

Scientists hope landmark international research will increase the survival rate for ovarian cancer - one of the deadliest forms of the disease.

SBS

SBS Source: SBS

Scientists hope landmark international research will increase the survival rate for ovarian cancer - one of the deadliest forms of the disease.

The Australian-led study has unlocked the genetic secrets that allow cancer cells to resist conventional chemotherapy, clearing the way for better targeted treatments.

After a series of unsuccessful chemotherapy treatments, ovarian cancer patient Rosemary Goulding is concentrating on living life to the full.

"I did go sky-diving back in January and had an absolute ball."

The sixty-five-year-old is welcoming ground-breaking new research that could lead to improved therapies for what's one of the hardest cancers to diagnose and treat.

"I was thrilled. It brought tears to my eyes to see that this is happening. I have two daughters and I have five grand-daughters."

The study has identified two major ways the body can reject chemotherapy drugs.

It found some patients have cancerous cells which actually pump the chemotherapy drugs out.

In other patients their DNA prevents the chemotherapy drugs from working.

Leader of the study, Professor David Bowtell from Melbourne's Peter MacCallum Cancer Centre, says until now, medical researchers haven't been able to work out how chemotherapy resistance has emerged in patients.

"This is the best shot that we have had in decades. Now that we have started to map these mechanism, when the cancer comes back we can develop tests that will predict whether a woman is likely to respond to a particular treatment or not."

It's hoped a key outcome of the largest DNA analysis ever conducted will be to improve the disease's survival rate, which has remained stubbornly low for women over the past thirty years compared with other cancers.

Ovarian Cancer Australia's Karen Livingstone say the findings are a game-changer for women.

"To be able to actually identify and individually target the treatment options means that there really will be better outcomes for women and that's what we really need."

Fourteen hundred women are diagnosed in Australia every year.

A thousand won't survive.

Not that Rosemary Goulding feels burdened by statistics.

"God has my days numbered and only he can tell me when my day is up. I have days when I don't feel so good, I days when I feel wonderful but I always put my shoes on and go for a walk...every day."


Share

3 min read

Published

Updated

By Gareth Boreham


Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world